Navigation Links
'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart

TUCSON, Ariz., July 22, 2014 /PRNewswire/ -- A central New York recipient of a SynCardia temporary Total Artificial Heart implant is home, discharged from University of Rochester's Strong Memorial Hospital with the Freedom® portable driver to wait for a matching donor heart.

Fontana, a 64-year-old retiree from a Syracuse architectural hardware company, suffered from heart disease—cardiomyopathy—for decades. He managed the condition with medications, an implantable defibrillator and a pacemaker.

Recently, the Camillus resident experienced ventricular tachycardia in which his heart would race until the pacemaker fired electrical pulses to normalize its rhythm. His doctors performed a procedure in February 2013 to fix the problem, but the condition returned.

By fall 2013, Fontana's conditioned worsened. "It became apparent quite quickly that we couldn't control it and we had to implant the Total Artificial Heart or he was not going to survive," says Dr. Jeffrey Alexis, Fontana's transplant cardiologist with the hospital's Program in Heart Failure and Transplantation. The implant was performed Sept. 24, 2013.

Like a heart transplant, the SynCardia Total Artificial Heart replaces the diseased heart's two failing ventricles and four heart valves. It is the only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

"This gives him time to stabilize, to build his strength up, to be able to walk, to feel stronger," says Alexis.

When Fontana became clinically stable, he was able to go home June 2, 2014 with the 13.5-pound Freedom portable driver, which powers the SynCardia Heart with precisely calibrated pulses of air and vacuum.

At home, Fontana spends time with his five grandkids, goes shopping and exercises on a treadmill.

"This machine, this artificial device is what's keeping me moving," Fontana told The Post-Standard in Syracuse.

Fontana has maintained his humor throughout. "I get a kick out of saying, 'I'm a heartless SOB.' I don't have a heart."

He also credits his wife, Toni, with keeping him motivated to get strong for his heart transplant.

"I'm still here and I'm glad for that," he told the newspaper. "I have a lot of life left to do."

For additional information, please visit:
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn
Share and Discover on Google+

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

More than 1,300 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.

The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old. The longest a patient has lived with a SynCardia Heart was nearly four years (1,374 days) before receiving a successful donor heart transplant Sept. 11, 2011.

SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital and live at home and in their communities. The wearable Freedom driver has been used by more than 175 patients, accounting for over 100 years of support.

Photo -

SOURCE SynCardia Systems, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
2. Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC
3. Genetic And Microbiome Discoveries Point The Way To New Treatments For Crohns & Colitis Patients
4. Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
5. Physicians to Pharmas: Provide Patient Services or Face Irrelevance
6. Simbionixs Innovative Solution for Patient Specific Simulation Receives Further Global Recognition
7. ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
8. Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a)
9. Innovative Lösung von Simbionix für patientenspezifische Simulation erhält noch mehr weltweite Anerkennung
10. NxStage Drives to Educate Kidney Patients
11. Mevesi Enhances Population Management Solution with Patient Education Videos
Post Your Comments:
(Date:12/1/2015)... 1, 2015  Today, AmerisourceBergen, a ... CareFront, a first-of-its-kind population health management program focused ... Designed to be built into existing employer benefit ... resources for their care and explains how to ... tools to help patients understand their treatment options ...
(Date:12/1/2015)... Dec. 1, 2015  Booth #3506 – Claymount is featuring ... annual meeting of the Radiological Society of North ... this year. Based in the Netherlands , ... Medical Systems (NYSE: VAR ) and is one of ... and solid state automatic exposure control systems for controlling dose ...
(Date:12/1/2015)... 1, 2015 --> ... van Leeuwenhoek Hospital (NKI-AVL), among the world,s largest ... Leksell Gamma Knife® Icon™, the company,s latest generation ... --> --> With the ... treatments, Leksell Gamma Knife Icon offers greatly enhanced ...
Breaking Medicine Technology:
(Date:12/1/2015)... Los Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... the United States, today announced that its iconic bottle has won top honors in ... drinks category. The Company also announced that it has been selected as a ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the start ... scientific research and discoveries, leading us to better understand the disease’s behavior. Globally, ... affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight on ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... of adjunctive imaging is the focus of numerous abstracts accepted for presentation here, ... 4, 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative breast ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, ... a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program ... as a finalist in the category of Digital Solutions for its innovative, industry-leading ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - CES, Las Vegas, ... Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, where they will ... Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among ...
Breaking Medicine News(10 mins):